March 19, 2022 Comments Off on New patent for Alnylam Pharms drug OXLUMO Posted in: Patent Added Annual Drug Patent Expirations for OXLUMO Oxlumo is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are eleven patents protecting this drug. This drug…
The post New patent for Alnylam Pharms drug OXLUMO appeared first on DrugPat…
March 19, 2022 Comments Off on New patent for Lantheus Medcl drug DEFINITY Posted in: Patent Added Annual Drug Patent Expirations for DEFINITY Definity is a drug marketed by Lantheus Medcl and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Lantheus Medcl drug DEFINITY appeared first on Drug…
